
Good News for Valiltramiprosate for Alzheimer’s (ALZ-801)
A twice-daily pill called ALZ-801 brings new hope to high-genetic-risk Alzheimer’s. Early findings suggest meaningful slowing of decline, stronger safety, and brain structure protection.

A twice-daily pill called ALZ-801 brings new hope to high-genetic-risk Alzheimer’s. Early findings suggest meaningful slowing of decline, stronger safety, and brain structure protection.

Trontinemab, an experimental drug developed by Roche, has sparked excitement in large trials for slowing Alzheimer’s faster and safer than anything before.

VIDEO + ARTICLE: A promising new oral therapy for Alzheimer’s is now recruiting participants across the USA and Australia, offering fresh hope to families affected by this devastating condition.

The big Alzheimer’s culprits are Amyloid and Tau. Biogen made Leqembi to treat amyloid. Now, they are betting on BIIB080 to treat tau. Learn how this exciting new treatment just got FDA Fast Track Designation.

Participants in a new study had inherited genetic variants that lead to early-onset Alzheimer’s. Among those who received the drug the longest – an average of eight years – the treatment lowered the risk of developing symptoms from essentially 100% to about 50%.

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise

Learn about 2025’s newly approved or potential Alzheimer’s drugs. These include Leqembi, Kisunla, Remternetug, Semaglutide, Trontinemab and Bepranemab.

New Alzheimer’s drugs clear brain plaque made of amyloid-beta. 9 years ago, researchers discovered another Alzheimer’s culprit called amyloid-ETA. Now, they’ve possibly figured out how it works. Learn how balancing these two suspects may hold the key to success in current clinical trials.

Right now, there are two FDA approved drugs to treat Alzheimer’s itself. Find out why Remternetug may soon get approval as a third, even better treatment.

“60 Minutes” interviews American neurosurgeon Dr. Ali Rezai. He is pioneering a new way to treat Alzheimer’s, focusing beams of ultrasound on the brain.

Scott Russell is living well with his Alzheimer’s. See how he has stayed active in his community, even starting a manageable home business.

Healthy living lowers Alzheimer’s risk. Today’s healthier lifestyles have witnessed a drop in the rate of Alzheimer’s. Watch The Wall Street Journal interview a new wave of adults changing lifestyles to keep Alzheimer’s away.

Delaying retirement can delay dementia in a big way. Learn why.

Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!

It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.

TEEPA CARE VIDEO: Learn about Alzheimer’s 6 stages. Teepa Snow shows what to expect, while keeping the focus on the person for whom you care.

Melvyn Amrine may not have remembered the details of his life since his Alzheimer’s diagnosis, but he sure proved that his love for his wife transcended memory.
No spam, only news and updates.



We use cookies and similar technologies to improve your experience, understand how our content is used, and support relevant advertising that helps keep Alzheimer’s Weekly free to readers. You can choose to accept, deny, or manage your preferences at any time. Declining certain cookies may affect features such as embedded videos, comments, and personalized advertising.